Core Points - As of December 31, 2025, EssilorLuxottica has a total of 463,289,594 shares outstanding [3] - The number of real voting rights, excluding treasury shares, is 463,190,305 [3] - The theoretical number of voting rights, including treasury shares, remains the same at 463,289,594 [3] - Voting rights for any shareholder are capped at 31%, as per the company's by-laws [3]

Core Insights - EssilorLuxottica is a global leader in the eyewear industry, known for brands like Ray-Ban and Oakley, and has a market capitalization of approximately $153.17 billion [1][4][5] - Citigroup has maintained a "Buy" rating for EssilorLuxottica, increasing the price target from EUR 296 to EUR 339 [1][5] - The company is advancing in the smart eyewear market with its Ray-Ban Meta glasses, which incorporate artificial intelligence, leading to a significant revenue boost [2][5] Financial Performance - The current stock price of EssilorLuxottica is $167.95, reflecting a slight decrease of 0.61% or $1.03 [3][5] - Over the past year, the stock has experienced volatility, with a high of $186.81 and a low of $118.18 [3] - The trading volume for the day is 4,405 shares on the OTC exchange, indicating investor interest in the company's future prospects [4][5] Market Challenges - Analysts have raised concerns regarding privacy issues and new competitors that could impact the growth of the smart eyewear segment [2][5]

Core Points - As of November 30, 2025, EssilorLuxottica has a total of 463,145,529 shares outstanding [3] - The number of real voting rights, excluding treasury shares, is 463,045,403 [3] - The theoretical number of voting rights, including treasury shares, is the same as the total shares outstanding, at 463,145,529 [3] - Voting rights for any shareholder are capped at 31%, as per the company's by-laws [3] Company Information - EssilorLuxottica is recognized as the global leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses [2] - The company's by-laws, which detail governance and regulations, are accessible on its official website [4]

Core Points - As of September 30, 2025, EssilorLuxottica has 463,145,529 shares outstanding and 461,160,993 real voting rights, excluding treasury shares [2][3] - The theoretical number of voting rights, including treasury shares, remains the same at 463,145,529 [3] - Voting rights for any shareholder are capped at 31%, as per the company's by-laws [3]

Core Viewpoint - PPG has launched a new non-methanol hard coating for ophthalmic lenses, addressing regulatory changes while ensuring durability performance [1] Company Summary - PPG introduced the PPG HI-GARD® Non-Methanol hard coating specifically for 1.5 standard index ophthalmic lenses [1] - The new formulation serves as a drop-in replacement for traditional methanol-based coatings, allowing prescription lens manufacturers to comply with evolving regulations [1] - The PPG Hi-Gard Non-Methanol coating provides the same level of scratch-resistant protection for plastic lens materials as its predecessors [1]

Core Points - As of August 31, 2025, EssilorLuxottica has a total of 463,145,529 shares outstanding [3] - The number of real voting rights, excluding treasury shares, is 461,157,737 [3] - The theoretical number of voting rights, including treasury shares, remains the same at 463,145,529 [3] - Voting rights for any shareholder are capped at 31%, as per the company's by-laws [3][2]

Core Insights - EssilorLuxottica has signed an agreement to acquire PUcore's division focused on the development, manufacturing, and sale of ophthalmic lens materials, enhancing its R&D and production capabilities for innovative high index lenses [1][2] - The acquisition includes a research and development unit, a materials production facility, and a sales office in South Korea, along with an intellectual property portfolio related to product formulations and production processes [2][3] - The transaction is expected to close by the end of 2025, pending regulatory approvals and customary closing conditions [4] Company Strategy - The acquisition aligns with EssilorLuxottica's commitment to improving standards in the research, development, and manufacturing of ophthalmic lenses, allowing the company to expand its portfolio of patents, technologies, and expertise [3] - By enhancing the production and formulation of high index monomers, the company aims to improve performance and sustainability across the ophthalmic industry [3]

Summary of Key Points Core Viewpoint - As of June 30, 2025, EssilorLuxottica has disclosed its share capital and voting rights, highlighting its position as a global leader in the ophthalmic lens, frame, and sunglasses market [2]. Group 1: Share Capital and Voting Rights - The total number of shares outstanding for EssilorLuxottica is 463,145,529 [3]. - The number of real voting rights, excluding treasury shares, is 461,150,585 [3]. - The theoretical number of voting rights, including treasury shares, remains at 463,145,529 [3]. - Voting rights for any shareholder are capped at 31%, as per the company's by-laws [3].

Summary of Key Points Core Viewpoint - As of May 31, 2025, EssilorLuxottica, a global leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses, disclosed its outstanding shares and voting rights [2]. Group 1: Share Capital and Voting Rights - Total shares outstanding amount to 457,507,201 [3]. - The number of real voting rights, excluding treasury shares, is 455,511,025 [3]. - The theoretical number of voting rights, including treasury shares, remains at 457,507,201 [3]. - Voting rights are capped at 31% for any shareholder, as per the company's by-laws [3].